About PBS Biotech
PBS Biotech is a Healthcare company based in Camarillo (United States) founded in 2006. PBS Biotech has raised $70.21 million across 4 funding rounds from investors including Broadoak Capital Partners and Avego. PBS Biotech offers products and services including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is PBS BIOTECH, INC. Its competitors include Hyalose and Choncept.
Company details
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies. Their products include PBS MINI for early-stage process development, PBS 3 for laboratory RD applications, PBS 15 for laboratory RD and pre-clinical applications, PBS 80 for laboratory RD applications to clinical pilot production applications, PBS 500 for clinical and commercial production applications.
- Headquarters Camarillo, United States
- SectorsHealthcare
- Email••••••••
- Website pbsbiotech.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Pbs Biotech, Inc
- Total Equity Funding$70.21M (USD)
in 4 rounds
- Latest Funding Round$17M (USD), Series B
Jan 2025
- InvestorsBroadoak Capital Partners
& 1 more
Products & Services of PBS Biotech
PBS Biotech offers a comprehensive portfolio of products and services, including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors.
Small-scale single-use bioreactor for cell culture in therapy development
Mini bioreactor for scaling cell therapy processes and yields
Mid-scale bioreactor for advanced cell and gene therapy applications
Larger bioreactor for production-scale cell therapy manufacturing
High-capacity bioreactor for extensive cell therapy development
Apps and channels of PBS Biotech
its YouTube channel PBS Biotech has 39 subscribers and 10 videos.
Videos from PBS Biotech
The most watched videos on PBS Biotech's YouTube channel, PBS Biotech (39 subscribers). Click a video to play it here.
More on PBS Biotech.
Funding Insights of PBS Biotech
PBS Biotech has successfully raised a total of $70.21M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $17 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $70.21M
- Total Rounds 4
- Last Round Series B — $17M
- First Round $10M
(Aug 2021)
- Investors Count 2
All 4 funding rounds of PBS Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $17M | Series B | – | – | |
| Sep 2024 | $8.5M | Series B | – | – | – |
| Jan 2023 | $34.71M | Series B | – | Avego | |
| Aug 2021 | $10M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in PBS Biotech
PBS Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadoak Capital Partners and Avego.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward the healthcare sector. | avego.com | Alpharetta, United States | ||
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States |
Investor details for PBS Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PBS Biotech
50 people are tracked at PBS Biotech (10 in leadership, 12 in board & advisors, 28 in team).
| Name | Role | Group |
|---|---|---|
Patrick Weydt | Executive Director of Engineering | Leadership |
Erica Ponce | Director of Quality Management | Leadership |
Mark Schneider | Vice President of Finance | Leadership |
Matthew Walker | Director of Information Technology | Leadership |
Yasunori Hashimura | Senior Director of Applications Eng | Leadership |
Michael Murguia | VP of Human Resources | Leadership |
Brian Lee | CEO and President | Leadership |
Joseph Petrosky III | Senior VP of Global Sales & Marketing | Leadership |
Joe Petrosky | Senior Vice President Of Global Sales | Leadership |
Rodney Torres | Sr. Director Quality Engineering And Regulatory | Leadership |
Lourie Zak | Advisor | Board & advisors |
Susan Lundeen | Advisor | Board & advisors |
Robert Baltera | Advisor | Board & advisors |
Geoffrey Slaff | Advisor | Board & advisors |
Manuel Carrondo | Advisor | Board & advisors |
Matthew Croughan | Advisor | Board & advisors |
Bill Rich | Advisor | Board & advisors |
Gregory Zeikus | Advisor | Board & advisors |
B.G. Rhee | Advisor | Board & advisors |
Andrew Gengos | Advisor | Board & advisors |
30 more people are available in the full profile.
Complete people profiles for PBS Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PBS Biotech
3 dated milestones of PBS Biotech across 19 years, from founding to its latest funding, stage changes and deals.
- Founded PBS Biotech is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B, of $17.0M.
Competitors of PBS Biotech
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hyalose.com | 2000 | Oklahoma, United States | Recombinant hyaluronic acid is manufactured in varying molecular sizes. | |||
| choncept.com | 2002 | Oklahoma, United States | Develops innovative chondroitin technologies through recombinant bacteria fermentation. |
Detailed competitors of PBS Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PBS Biotech
The website of PBS Biotech (pbsbiotech.com) receives about 3K visits a month.
- Monthly visits3K
▲ 25.8% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as PBS Biotech (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pbs Biotech
Complete news archive for PBS Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PBS Biotech
PBS Biotech was founded in 2006 and raised its 1st funding round 15 years after it was founded.
PBS Biotech is headquartered in Camarillo, United States. It is registered at Camarillo, California, United States.
PBS Biotech is a funded company, having raised a total of $70.21M across 4 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Aug 2021.
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies. Their products include PBS MINI for early-stage process development, PBS 3 for laboratory RD applications, PBS 15 for laboratory RD and pre-clinical applications, PBS 80 for laboratory RD applications to clinical pilot production applications, PBS 500 for clinical and commercial production applications.
PBS Biotech offers PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors.
PBS Biotech has 2 investors. Key investors include Broadoak Capital Partners, and Avego.
PBS Biotech operates through Pbs Biotech, Inc.